Publications by authors named "Pei-jun Zhou"

Aims: The population pharmacokinetic (PPK) model-based machine learning (ML) approach offers a novel perspective on individual concentration prediction. This study aimed to establish a PPK-based ML model for predicting tacrolimus (TAC) concentrations in Chinese renal transplant recipients.

Methods: Conventional TAC monitoring data from 127 Chinese renal transplant patients were divided into training (80%) and testing (20%) datasets.

View Article and Find Full Text PDF

There is significant enterohepatic circulation (EHC) during the disposition of mycophenolic acid (MPA). The aim of this study was to elucidate factors influencing the EHC of MPA in Chinese adult renal allograft recipients. After 2 weeks of therapy with mycophenolate mofetil or enteric-coated mycophenolate sodium, blood samples were collected from 125 patients at 0 to 12 hours post-administration and MPA concentrations were determined.

View Article and Find Full Text PDF

Purpose: Intracellular exposure of tacrolimus (TAC) may be a better marker of therapeutic effect than whole blood exposure. We aimed to evaluate the influence of genetic polymorphism on the pharmacokinetics of TAC in peripheral blood mononuclear cells (PBMCs) and develop limited sampling strategy (LSS) models to estimate the area under the curve (AUC) in the PBMC of Chinese renal transplant patients.

Methods: Ten blood samples of each of the 23 renal transplant patients were collected 0-12h after 14 (10-18) days of TAC administration.

View Article and Find Full Text PDF

Gastric cancer (GC) poses a serious threat worldwide with unfavorable prognosis mainly due to late diagnosis and limited therapies. Therefore, precise molecular classification and search for potential targets are required for diagnosis and treatment, as GC is complicated and heterogeneous in nature. Accumulating evidence indicates that epigenetics plays a vital role in gastric carcinogenesis and progression, including histone modifications, DNA methylation and non-coding RNAs.

View Article and Find Full Text PDF
Article Synopsis
  • Valganciclovir (VGCV) is a prodrug that converts to ganciclovir (GCV), and this study aimed to create a population pharmacokinetic (PPK) model to analyze GCV levels in Chinese kidney transplant patients.
  • Seventy recipients received either 450 mg or 900 mg of VGCV daily, and their blood was sampled after five days to measure plasma GCV levels, using nonlinear mixed-effects modeling for analysis.
  • The study found that GCV pharmacokinetics were best explained by a 2-compartment model, with clearance significantly affected by creatinine levels, and an effective limited sampling strategy was established for calculating GCV's area under the curve (AUC)
View Article and Find Full Text PDF
Article Synopsis
  • Monitoring immunosuppressant levels like mycophenolic acid (MPA), cyclosporin A (CsA), and tacrolimus (TAC) in peripheral blood mononuclear cells (PBMCs) can help personalize treatment for kidney transplant patients.
  • Researchers developed a liquid chromatography-tandem mass spectrometry method to measure these levels and analyze their pharmacokinetics in 27 Chinese renal transplant recipients.
  • The study found that the method effectively tracks immunosuppressant levels in PBMCs, revealing significant individual variability, which could improve personalized therapy for patients post-transplant.
View Article and Find Full Text PDF

Objectives: Valganciclovir (VGCV) treatment is recommended for the prevention of cytomegalovirus (CMV) infection in renal allograft recipients. The aim of the present study is to investigate the pharmacokinetic characteristics of ganciclovir (GCV) after administration of VGCV in Chinese adult renal allograft recipients and estimate the exposure to GCV using limited sampling strategy (LSS).

Methods: Forty Chinese renal allograft recipients were given 450 mg or 900 mg VGCV daily.

View Article and Find Full Text PDF

The aim of the present study is to establish a population pharmacokinetic (PPK) model of mycophenolic acid (MPA) and limited sampling strategy models for the estimation of MPA exposure in Chinese adult renal allograft recipients following oral administration of enteric coated mycophenolate sodium (EC-MPS). A total of 74 sets of full pharmacokinetic profiles and 47 sets of MPA-sparing samples were collected from 102 renal transplant recipients who received oral EC-MPS. The MPA concentration was determined by an enzyme-multiplied immunoassay technique, and the pathophysiologic data were recorded.

View Article and Find Full Text PDF

Mycophenolate mofetil (MMF) is an important immunosuppressant used in renal transplantation, and mycophenolic acid (MPA) is the active component released from the ester prodrug MMF. The objective of this study was to investigate the population pharmacokinetics of mycophenolic acid (MPA) following oral administration of MMF in Chinese adult renal transplant recipients and to identify factors that explain MPA pharmacokinetic variability. Pharmacokinetic data for MPA and covariate information were retrospectively collected from 118 patients (79 patients were assigned to the group for building the population pharmacokinetic model, while 39 patients were assigned to the validation group).

View Article and Find Full Text PDF

Objective: To analyze ITS region and matK gene sequences of three medicinal Phlomis plants,in order to provide molecular basis for identifying and protecting their wild resources.

Methods: PCR and sequencing were conducted on Phlomis likiangensis,Phlomis melanantha and Phlomis betonicoides wild populations by primers pairs ITS4 / ITS5 and matKXF / matK5 R.

Results: The smallest inter-K2 P genetic distance was further than the largest intra-K2 P genetic distance in Phlomis likiangensis, Phlomis melanantha and Phlomis betonicoides.

View Article and Find Full Text PDF

Objective: To analyze and compare the ITS sequences of Aconitum vilmorinianum and its medicinal adulterant Aconitum austroyunnanense.

Methods: Total genomic DNA were extracted from sample materials by improved CTAB method, ITS sequences of samples were amplified using PCR systems, directly sequenced and analyzed using software DNAStar, ClustalX1.81 and MEGA 4.

View Article and Find Full Text PDF
Article Synopsis
  • Renal cell carcinoma (RCC) often metastasizes and shows resistance to existing therapies, prompting the exploration of new treatment options.
  • This study investigated the effectiveness of a specific treatment—CpG ODN1826—on RCC by observing its effects when injected into mice with human RCC tumors.
  • The results showed that CpG ODN1826 significantly reduced tumor growth, improved survival rates in the mice, and enhanced the immune response, particularly increasing the activity of natural killer cells and levels of interleukin-12.
View Article and Find Full Text PDF

Objectives: To investigate the pharmacokinetics of mycophenolic acid (MPA) in Chinese adult renal allograft recipients, and to generate the validated model equations for estimation of the MPA area under the plasma concentration-time curve from 0 to 12 hours (AUC(12)) with a limited sampling strategy.

Patients And Methods: The pharmacokinetics in 75 Chinese renal allograft recipients treated with mycophenolate mofetil 2 g/day in combination with cyclosporin and corticosteroids were determined. The MPA concentration was assayed by high-performance liquid chromatography at pre-dose (C(0)) and at 0.

View Article and Find Full Text PDF

Aim: To investigate the pharmacokinetics of mycophenolic acid (MPA), an active metabolite of mycophenolate mofetil (MMF) in Chinese adult liver transplant patients.

Methods: Thirty-eight liver transplant patients (male 30, female 8) receiving MMF 1.0 g, twice daily in accordance with the recommended regimen were included in this study.

View Article and Find Full Text PDF

Background: This study was to evaluate whether anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways can act as potent immunoregulatory cells in vitro and prolong cardiac allograft survival after adoptive transfer.

Methods: Anergic cells were induced in vitro by the addition of anti-CD154 and anti-CD80 monoclonal antibodies (mAbs) to primary MLR (mixed lymphocyte reaction) consisting of BALB/c as responder and C3H as stimulator. Anergic cells were added to a newly formed MLR in assessing the regulatory capacity and antigen specificity of anergic cells.

View Article and Find Full Text PDF

Objective: To investigate the expression of fractalkine (FKN) and its receptor CX3CR1 in cardiac allografts and the effect of Cyclosporin A (CsA).

Methods: Three groups of rats underwent heterotopic cardiac transplantation, 45 cases in each group and 5 cases in control group: SD to SD regarded as isograft group (group A), Wistar to SD divided into CsA untreated allograft group (group B) and CsA treated allograft group (group C), normal SD rats as control group. The FKN mRNA expression was detected by one-step RT-PCR method and the expression of FKN and CX3CR1 protein was detected by standard ABC immunohistochemical technique.

View Article and Find Full Text PDF